Aragen Life Sciences Ltd.

Use of Proceeds

Promoters

Book Running Lead Managers

Promoter Shareholding

About the Company

We are a fully integrated contract research, development and manufacturing organization (“CRDMO”) serving global innovator companies and emerging firms in the life sciences industry. We offer comprehensive solutions across the entire drug development lifecycle spanning contract discovery and pre-clinical research solutions (“CRO” or “Contract Research”) and contract development and manufacturing solutions (“CDMO”) for both small molecules and biologics. With more than 25 years of operations, we have become the largest CRDMO among the assessed Indian peers in terms of number of solutions offered across the drug development value chain as of March 31, 2026 (Source: F&S Report). We have become one of the top three largest Indian CRDMOs in terms of operating revenue among the assessed Indian peers, operating in a global CRDMO market estimated at USD 171 billion in Fiscal 2026 (Source: F&S Report). Our platform focuses on life sciences companies that are engaged in new chemical entities (“NCEs”) and new biological entities (“NBEs”) and we served as a strategic partner to 591 customers globally in Fiscal 2026, across key markets including the United States, Europe, Japan, India and other APAC markets. Our customer base comprises Big Pharma companies, large pharmaceutical companies, small / biotechnology companies and mid-sized pharmaceutical companies operating across pharmaceuticals, biotechnology, animal health, agrochemicals and specialty chemicals. We worked with 16 of the Top 20 Big Pharma customers as of March 31, 2026 (Source: F&S Report). We also recorded the second highest revenue from operations growth between Fiscal 2025 and Fiscal 2026 among the assessed Indian peers, according to the F&S Report.